125 related articles for article (PubMed ID: 9519730)
1. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects.
Calles-Escandon J; Mirza SA; Sobel BE; Schneider DJ
Diabetes; 1998 Feb; 47(2):290-3. PubMed ID: 9519730
[TBL] [Abstract][Full Text] [Related]
2. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat.
Pandolfi A; Giaccari A; Cilli C; Alberta MM; Morviducci L; De Filippis EA; Buongiorno A; Pellegrini G; Capani F; Consoli A
Acta Diabetol; 2001; 38(2):71-6. PubMed ID: 11757804
[TBL] [Abstract][Full Text] [Related]
3. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
4. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
5. Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids.
Schneider DJ; Sobel BE
Coron Artery Dis; 1996 Nov; 7(11):813-7. PubMed ID: 8993938
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans.
Stegenga ME; van der Crabben SN; Levi M; de Vos AF; Tanck MW; Sauerwein HP; van der Poll T
Diabetes; 2006 Jun; 55(6):1807-12. PubMed ID: 16731846
[TBL] [Abstract][Full Text] [Related]
7. Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects.
Carmassi F; Morale M; Ferrini L; Dell'Omo G; Ferdeghini M; Pedrinelli R; De Negri F
Am J Med; 1999 Oct; 107(4):344-50. PubMed ID: 10527036
[TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients.
Lormeau B; Aurousseau MH; Valensi P; Paries J; Attali JR
Metabolism; 1997 Sep; 46(9):1074-9. PubMed ID: 9284899
[TBL] [Abstract][Full Text] [Related]
9. The effect of insulin treatment on the balance between tissue plasminogen activator and plasminogen activator inhibitor-1 in type 2 diabetic patients.
Vukovich T; Proidl S; Knöbl P; Teufelsbauer H; Schnack C; Schernthaner G
Thromb Haemost; 1992 Sep; 68(3):253-6. PubMed ID: 1440487
[TBL] [Abstract][Full Text] [Related]
10. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
[TBL] [Abstract][Full Text] [Related]
12. Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation.
Hansen J; Rinnov A; Krogh-Madsen R; Fischer CP; Andreasen AS; Berg RM; Møller K; Pedersen BK; Plomgaard P
Diabetes Metab Res Rev; 2013 Sep; 29(6):463-72. PubMed ID: 23564759
[TBL] [Abstract][Full Text] [Related]
13. No evidence for short-term regulation of plasminogen activator inhibitor activity by insulin in man.
Vuorinen-Markkola H; Puhakainen I; Yki-Järvinen H
Thromb Haemost; 1992 Jan; 67(1):117-20. PubMed ID: 1615465
[TBL] [Abstract][Full Text] [Related]
14. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
Bastard JP; Bruckert E; Robert JJ; Ankri A; Grimaldi A; Jardel C; Hainque B
Int J Obes Relat Metab Disord; 1995 Nov; 19(11):836-8. PubMed ID: 8589788
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man.
Krebs M; Geiger M; Polak K; Vales A; Schmetterer L; Wagner OF; Waldhäusl W; Binder BR; Roden M
Thromb Haemost; 2003 Sep; 90(3):422-8. PubMed ID: 12958610
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.
Stegenga ME; van der Crabben SN; Blümer RM; Levi M; Meijers JC; Serlie MJ; Tanck MW; Sauerwein HP; van der Poll T
Blood; 2008 Jul; 112(1):82-9. PubMed ID: 18316629
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
Ehrmann DA; Schneider DJ; Sobel BE; Cavaghan MK; Imperial J; Rosenfield RL; Polonsky KS
J Clin Endocrinol Metab; 1997 Jul; 82(7):2108-16. PubMed ID: 9215280
[TBL] [Abstract][Full Text] [Related]
19. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men.
Rao AK; Chouhan V; Chen X; Sun L; Boden G
Diabetes; 1999 May; 48(5):1156-61. PubMed ID: 10331423
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway.
Gabriely I; Yang XM; Cases JA; Ma XH; Rossetti L; Barzilai N
Atherosclerosis; 2002 Jan; 160(1):115-22. PubMed ID: 11755928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
